This study adds to the body of evidence pertaining to the role of immune checkpoint blockade in HCC.* *Relevance section written by JCO Associate Editor Eileen M. O'Reilly, MD. Eligible patients were ...
"It did not matter what they thought about placebos," Hoenemeyer says. "Some people who thought it wouldn't do anything had a good response; others who believed it would help didn't have a response." ...
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia PAKT was an investigator-led, placebo-controlled, randomized phase II trial performed in 42 academic ...
Pain-predominant disorders of gut-brain interaction (DGBIs) in children - such as functional abdominal pain (FAP) and irritable bowel syndrome (IBS) - can lead to disabling symptoms, poor quality of ...
Please provide your email address to receive an email when new articles are posted on . Ustekinumab failed to demonstrate superiority to placebo among patients with active systemic lupus erythematosus ...
Please provide your email address to receive an email when new articles are posted on . Significant improvements in clinical remission rates were observed at 12 weeks with risankizumab vs. placebo (20 ...
The placebo response is statistically, and possibly clinically, significant in patients with OAB, according to authors of a new systematic review. Placebo improves the symptoms of overactive bladder ...
Sticking needles in someone’s body is not a placebo therapy, or at least not an effective one, argue two letters in today’s issue of Archives of Internal Medicine. From personal experience I’d argue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results